Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

A history of the development of Brucella vaccines.

Avila-Calderón ED, Lopez-Merino A, Sriranganathan N, Boyle SM, Contreras-Rodríguez A.

Biomed Res Int. 2013;2013:743509. doi: 10.1155/2013/743509. Epub 2013 Jun 3. Review.

2.

Research progress in live attenuated Brucella vaccine development.

Wang Z, Wu Q.

Curr Pharm Biotechnol. 2013;14(10):887-96. Review.

PMID:
24372253
3.

Towards a Brucella vaccine for humans.

Perkins SD, Smither SJ, Atkins HS.

FEMS Microbiol Rev. 2010 May;34(3):379-94. doi: 10.1111/j.1574-6976.2010.00211.x. Epub 2010 Jan 19. Review.

4.

Acellular vaccines for ovine brucellosis: a safer alternative against a worldwide disease.

Martins Rda C, Irache JM, Gamazo C.

Expert Rev Vaccines. 2012 Jan;11(1):87-95. doi: 10.1586/erv.11.172. Review.

PMID:
22149711
5.

Lipopolysaccharide as a target for brucellosis vaccine design.

Conde-Álvarez R, Arce-Gorvel V, Gil-Ramírez Y, Iriarte M, Grilló MJ, Gorvel JP, Moriyón I.

Microb Pathog. 2013 May;58:29-34. doi: 10.1016/j.micpath.2012.11.011. Epub 2012 Dec 5. Review.

PMID:
23219811
6.

Brucellosis vaccines for livestock.

Goodwin ZI, Pascual DW.

Vet Immunol Immunopathol. 2016 Nov 15;181:51-58. doi: 10.1016/j.vetimm.2016.03.011. Epub 2016 Mar 16. Review.

PMID:
27032465
7.

Protective efficacy and safety of Brucella melitensis 16MΔmucR against intraperitoneal and aerosol challenge in BALB/c mice.

Arenas-Gamboa AM, Rice-Ficht AC, Kahl-McDonagh MM, Ficht TA.

Infect Immun. 2011 Sep;79(9):3653-8. doi: 10.1128/IAI.05330-11. Epub 2011 Jun 27. Erratum in: Infect Immun. 2011 Dec;79(12):5040.

8.

Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.

Rajasekaran P, Surendran N, Seleem MN, Sriranganathan N, Schurig GG, Boyle SM.

Vaccine. 2011 Apr 12;29(17):3106-10. doi: 10.1016/j.vaccine.2011.02.054. Epub 2011 Mar 3.

PMID:
21376799
9.

Immunization with recombinant Brucella species outer membrane protein Omp16 or Omp19 in adjuvant induces specific CD4+ and CD8+ T cells as well as systemic and oral protection against Brucella abortus infection.

Pasquevich KA, Estein SM, García Samartino C, Zwerdling A, Coria LM, Barrionuevo P, Fossati CA, Giambartolomei GH, Cassataro J.

Infect Immun. 2009 Jan;77(1):436-45. doi: 10.1128/IAI.01151-08. Epub 2008 Nov 3. Erratum in: Infect Immun. 2009 Apr;77(4):1719.. Samartino, Clara García [corrected to García Samartino, Clara].

10.

The 16MΔvjbR as an ideal live attenuated vaccine candidate for differentiation between Brucella vaccination and infection.

Wang Y, Bai Y, Qu Q, Xu J, Chen Y, Zhong Z, Qiu Y, Wang T, Du X, Wang Z, Yu S, Fu S, Yuan J, Zhen Q, Yu Y, Chen Z, Huang L.

Vet Microbiol. 2011 Aug 5;151(3-4):354-62. doi: 10.1016/j.vetmic.2011.03.031. Epub 2011 Apr 4.

PMID:
21530111
11.

[Human vaccination against brucellosis (Charles Nicolle)].

Roux J.

Bull Acad Natl Med. 1986 Feb;170(2):289-92. French. No abstract available.

PMID:
3527369
12.

[The application and research advances of Brucella vaccines].

Ding JB, Mao KR, Cheng JS, Dai ZH, Jiang YW.

Wei Sheng Wu Xue Bao. 2006 Oct;46(5):856-9. Review. Chinese.

PMID:
17172046
13.

Extended safety and efficacy studies of the attenuated Brucella vaccine candidates 16 M(Delta)vjbR and S19(Delta)vjbR in the immunocompromised IRF-1-/- mouse model.

Arenas-Gamboa AM, Rice-Ficht AC, Fan Y, Kahl-McDonagh MM, Ficht TA.

Clin Vaccine Immunol. 2012 Feb;19(2):249-60. doi: 10.1128/CVI.05321-11. Epub 2011 Dec 14.

14.

Confronting the barriers to develop novel vaccines against brucellosis.

Oliveira SC, Giambartolomei GH, Cassataro J.

Expert Rev Vaccines. 2011 Sep;10(9):1291-305. doi: 10.1586/erv.11.110. Review.

PMID:
21919619
15.

Brucellosis: a re-emerging zoonosis.

Seleem MN, Boyle SM, Sriranganathan N.

Vet Microbiol. 2010 Jan 27;140(3-4):392-8. doi: 10.1016/j.vetmic.2009.06.021. Epub 2009 Jun 21. Review.

PMID:
19604656
16.

The use of green fluorescent protein as a marker for Brucella vaccines.

Chacón-Díaz C, Muñoz-Rodríguez M, Barquero-Calvo E, Guzmán-Verri C, Chaves-Olarte E, Grilló MJ, Moreno E.

Vaccine. 2011 Jan 10;29(3):577-82. doi: 10.1016/j.vaccine.2010.09.109. Epub 2010 Nov 4.

PMID:
21056079
17.

Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.

Zhao Z, Li M, Luo D, Xing L, Wu S, Duan Y, Yang P, Wang X.

Vaccine. 2009 Aug 20;27(38):5214-9. doi: 10.1016/j.vaccine.2009.06.075. Epub 2009 Jul 9.

PMID:
19596411
18.

Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine.

Yang Y, Wang L, Yin J, Wang X, Cheng S, Lang X, Wang X, Qu H, Sun C, Wang J, Zhang R.

Mol Immunol. 2011 Oct;49(1-2):175-84. doi: 10.1016/j.molimm.2011.08.009. Epub 2011 Sep 22.

PMID:
21943783
19.

Recent developments in livestock and wildlife brucellosis vaccination.

Olsen SC.

Rev Sci Tech. 2013 Apr;32(1):207-17. Review.

PMID:
23837378

Supplemental Content

Support Center